Sign in

Scott M. Brinker

President and Chief Executive Officer at HEALTHPEAK PROPERTIES
Board
Since October 2022
Age
48 years
Tenure
Joined Healthpeak Properties, Inc. in March 2018 as Executive Vice President and Chief Investment Officer, was promoted to President and Chief Investment Officer in January 2020, and appointed President and Chief Executive Officer in October 2022.

Also at HEALTHPEAK PROPERTIES

AGM
Adam G. Mabry
Chief Investment Officer
ABP
Ankit B. Patadia
Executive Vice President and Treasurer – Corporate Finance
KOM
Kelvin O. Moses
Executive Vice President – Investments and Portfolio Management

About

Scott M. Brinker is a 48-year-old executive currently serving as the President and Chief Executive Officer of Healthpeak Properties, Inc. (ticker: DOC). He has extensive experience in the healthcare real estate investment trust (REIT) industry and has held multiple senior leadership roles since joining the company.

Beginning his tenure as Executive Vice President and Chief Investment Officer in March 2018, he advanced to become President and Chief Investment Officer in January 2020, reflecting his growing responsibilities and expertise in corporate finance, asset management, and investor relations.

In October 2022, he was appointed as President and Chief Executive Officer, a role in which he continues to drive strategic initiatives and operational excellence at Healthpeak Properties, Inc. His career has been further enriched by prior leadership roles at Welltower Inc. and his active involvement on the Executive Board of Nareit, underscoring a solid professional foundation in investment management and corporate strategy.

$DOC Performance Under Scott M. Brinker

Past Roles

OrganizationRoleDate RangeDetails
Healthpeak Properties, Inc. (DOC) President and Chief Investment Officer January 2020 – October 2022 Preceded appointment as President and CEO
Healthpeak Properties, Inc. (DOC) Executive Vice President and Chief Investment Officer March 2018 – December 2019 Former role at DOC
Welltower Inc. (NYSE: WELL) Executive Vice President and Chief Investment Officer July 2014 – January 2017 Held leadership role at a healthcare REIT
Welltower Inc. (NYSE: WELL) Executive Vice President – Investments February 2012 – July 2014 Held multiple leadership roles at Welltower

External Roles

OrganizationRoleDate RangeDetails
National Association of Real Estate Investment Trusts (Nareit) Executive Board Member N/A Active position outside of DOC

Fixed Compensation

Data from  FY 2024
Component NameAmountPayment ScheduleAdditional Details
Base Salary$750,000 Annual 2024Fixed base salary
401(k) Matching Contribution$13,800 Annual 2024Matching contribution
Broad-Based Employee Wellness Program$500 Annual 2024Employee wellness program
Executive Medical Examination$4,200 Annual 2024Annual executive exam
Executive Financial Planning Services$8,943 Annual 2024Financial planning services
Retentive Stock Awards137,532 shares; Fair Value: $2,166,129 Grant Date 2024Stock award granted with specified fair value

Performance Compensation

Data from  FY 2024

2024 Annual Cash Incentive Compensation

MetricWeightTarget/OutcomePayout Details
Normalized FFO Per Share55% (Financial Metrics)Outcome: $1.81 Payout at 183.3%
Run-Rate Synergies55% (Financial Metrics)Outcome: $53.6 million Payout at 200%
Corporate Impact Performance Metric15%Not quantified; evaluated on sustainability, culture, and governance criteria Impact-based payout

Award Opportunity Levels:

  • Threshold (50%): $575,000
  • Target (100%): $1,150,000
  • High (150%): $1,725,000
  • Outperformance (200%): $2,041,250

Additional Details:

  • Grant Date: February 16, 2024
  • Grant Date Fair Value: $3,548,277
  • Payouts are interpolated linearly between the defined levels with no bonus for performance below threshold

2024 Performance-Based Awards

Metric/ComponentTarget/ThresholdOutcome / AwardAdditional Details
Net Debt to Adjusted EBITDAreThreshold: 6.0x; Target: 5.5x; High: 5.0xPayout moves from 0% at 6.0x to 200% at 5.0x Performance evaluated based on financial leverage
Normalized FFO Per ShareMinimum hurdle: $1.30Outcome exceeded $1.30 Required for Retentive Awards
TSR (Total Shareholder Return)Performance period: 2024 to 2026Payout range: 0% to 200% based on relative performance Evaluation over a 3-year period

Shares Granted (Based on Performance):

  • Threshold: 103,148 shares
  • Target: 206,295 shares
  • Maximum: 412,590 shares

Vesting Schedule & Conditions:

  • Awards vest at the end of the performance period on December 31, 2026
  • Vesting is contingent upon achieving the specified performance metrics for both financial and market-based measures

Additional Information:

  • A Monte Carlo simulation was used to calculate the grant date fair value, incorporating a stock price volatility of 26.0% and a risk-free rate of 4.52%

This table and explanation detail the performance compensation components, including required metrics, percentages, thresholds, targets, vesting conditions, and evaluation periods for 2024.